يعرض 1 - 10 نتائج من 14 نتيجة بحث عن '"Karin Holmsten"', وقت الاستعلام: 1.16s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
  4. 4
  5. 5

    المصدر: Carus, A, Holmsten, K, Pappot, H & Ullén, A 2022, ' The optimal neoadjuvant chemotherapy regime for muscle-invasive bladder cancer : still an open question? ', Acta Oncologica, vol. 61, no. 12, pp. 1515-1516 . https://doi.org/10.1080/0284186X.2022.2153620Test

  6. 6

    المصدر: Holmsten, K, Omland, L H, Als, A B, Agerbæk, M, Dohn, L H, Lindberg, H, Jensen, N V, Carus, A, Moe, M, Hosseini, A, Radkiewicz, C, Pappot, H & Ullén, A 2022, ' Implications for Efficacy and Safety of Total Dose and Dose-Intensity of Neoadjuvant Gemcitabine-Cisplatin in Muscle-Invasive Bladder Cancer : Three-Week Versus Four-Week Regimen ', Bladder Cancer, vol. 8, no. 1, pp. 71-80 . https://doi.org/10.3233/BLC-211556Test

    وصف الملف: application/pdf

  7. 7

    المصدر: Holmsten, K, Jensen, N V, Mouritsen, L S, Jonsson, E, Mellnert, C, Agerbæk, M, Nilsson, C, Moe, M, Carus, A, Öfverholm, E, Lahdenperä, O, Brandberg, Y, Johansson, H, Hellström, M, Maase, H V D, Pappot, H & Ullén, A 2020, ' Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma : A randomised phase II trial (VINGEM) ', European Journal of Cancer, vol. 127, pp. 173-182 . https://doi.org/10.1016/j.ejca.2019.08.033Test

    وصف الملف: application/pdf

  8. 8
  9. 9
  10. 10

    المصدر: Shah, C H, Pappot, H, Agerbæk, M, Holmsten, K, Jäderling, F, Yachnin, J, Grybäck, P, von der Maase, H & Ullén, A 2019, ' Safety and Activity of Sorafenib in Addition to Vinflunine in Post-Platinum Metastatic Urothelial Carcinoma (Vinsor) : Phase I Trial ', Oncologist, vol. 24, no. 6, pp. 745-e213 . https://doi.org/10.1634/theoncologist.2018-0795Test
    The Oncologist